blog posts First human clinical trials of anti-cancer agent PAC-1 show promise Dec 22, 2022 9:45 am by Diana YatesResearch Share on Facebook Tweet Email Images Phase I clinical trial of an anti-cancer agent developed by U of I researchers found only minor side effects in patients with end-stage cancers. It stalled the growth of tumors in five people and reduced tumor size in two of those patients. Share on Facebook Tweet Email
